From the archives of the AFIP: Fat-containing lesions of the retroperitoneum: Radiologic-pathologic correlation

Radiographics

Volumn 29, Issue 1, 2009, Pages 261-290

  Craig, William D ^a,b   Fanburg Smith, Julie C ^a   Henry, Leonard R ^b,c   Guerrero, Rubén ^d   Barton, Joel H ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAABDOMINAL FAT; LIPOMA; LIPOMATOSIS; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RETROPERITONEAL TUMOR;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIPOMATOSIS; MALE; MIDDLE AGED; NEOPLASMS, ADIPOSE TISSUE; RETROPERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63049086666     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.291085203     Document Type: Article

References (109)

1. Engels EP. Sigmoid colon and urinary bladder in high fixation: roentgen changes simulating pelvic tumor. Radiology 1959;72:419-422.
2. Radinsky S, Cabal E, Shields J. Pelvic lipomatosis. Urology 1976;7:108-111.
3. Heyns CF. Pelvic lipomatosis: a review of its diagnosis and management. J Urol 1991;146:267-273.
4. Saxton HS. Lipomatosis. In: Pollack A, ed. Clinical urography. Philadelphia, Pa: Saunders, 2000; 2866-2877.
5. Waligore MP, Stephens DH, Soule EH, McLeod RA. Lipomatous tumors of the abdominal cavity: CT appearance and pathologic correlation. AJR Am J Roentgenol 1981;137:539-545.
6. Fogg LB, Smyth JW. Pelvic lipomatosis: a condition simulating pelvic neoplasm. Radiology 1968;90: 558-564.
7. Malter IJ, Omell GH. Pelvic lipomatosis in a woman: a case report. Obstet Gynecol 1971;37:63-66.
8. Golding PL, Singh M, Worthington B. Bilateral ureteric obstruction caused by benign pelvic lipomatosis. Br J Surg 1972;59:69-72.
9. Albert DJ, Herman GP, Persky L. Pelvic lipomatosis: report of three cases. J Med 1972;3:282-292.
10. Klein FA, Smith MJ, Kasenetz I. Pelvic lipomatosis: 35-year experience. J Urol 1988;139:998-1001.
11. Johnston OL, Bracken RB, Ayala AG. Vesical adenocarcinoma occurring in patient with pelvic lipomatosis. Urology 1980;15:280-282.
12. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 5th ed. St Louis, Mo: Mosby, 2007.
13. Ida CM, Wang X, Erickson-Johnson MR, et al. Primary retroperitoneal lipoma: a soft tissue pathology heresy?: report of a case with classic histologic, cytogenetics, and molecular genetic features. Am J Surg Pathol 2008;32:951-954.
14. Chung EB, Enzinger FM. Benign lipoblastomatosis: an analysis of 35 cases. Cancer 1973;32:482-492.
15. Moholkar S, Sebire NJ, Roebuck DJ. Radiologicalpathological correlation in lipoblastoma and lipoblastomatosis. Pediatr Radiol 2006;36:851-856.
16. Collins MH, Chatten J. Lipoblastoma/lipoblastomatosis: a clinicopathologic study of 25 tumors. Am J Surg Pathol 1997;21:1131-1137.
17. Bourelle S, Viehweger E, Launay F, et al. Lipoblastoma and lipoblastomatosis. J Pediatr Orthop B 2006;15:356-361.
18. Reiseter T, Nordshus T, Borthne A, Roald B, Naess P, Schistad O. Lipoblastoma: MRI appearances of a rare paediatric soft tissue tumour. Pediatr Radiol 1999;29:542-545.
19. McVay MR, Keller JE, Wagner CW, Jackson RJ, Smith SD. Surgical management of lipoblastoma. J Pediatr Surg 2006;41:1067-1071.
20. Mognato G, Cecchetto G, Carli M, et al. Is surgical treatment of lipoblastoma always necessary? J Pediatr Surg 2000;35:1511-1513.
21. Dilley AV, Patel DL, Hicks MJ, Brandt ML. Lipoblastoma: pathophysiology and surgical management. J Pediatr Surg 2001;36:229-231.
22. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129-134.
23. Murphey MD, Arcara LK, Fanburg-Smith J. Imaging of musculoskeletal liposarcoma with radiologicpathologic correlation. RadioGraphics 2005;25: 1371-1395.
24. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 2002;26:601-616.
25. Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997;21:271-281.
26. Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006;37:1123-1129.
27. Antonescu CR, Elahi A, Humphrey M, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn 2000;2:132-138.
28. Matsui Y, Ueda T, Kubo T, et al. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma. Biochem Biophys Res Commun 2006;348:437-440.
29. De Cecco L, Gariboldi M, Reid JF, et al. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUSCHOP transcript. Histopathology 2005;46:334-341.
30. Ohguri T, Aoki T, Hisaoka M, et al. Differential diagnosis of benign peripheral lipoma from welldifferentiated liposarcoma on MR imaging: is comparison of margins and internal characteristics useful? AJR Am J Roentgenol 2003;180:1689-1694.
31. Galant J, Marti-Bonmati L, Saez F, Soler R, Alcala-Santaella R, Navarro M. The value of fatsuppressed T2 or STIR sequences in distinguishing lipoma from well-differentiated liposarcoma. Eur Radiol 2003;13:337-343.
32. London J, Kim EE, Wallace S, Shirkhoda A, Coan J, Evans H. MR imaging of liposarcomas: correlation of MR features and histology. J Comput Assist Tomogr 1989;13:832-835.
33. Song T, Shen J, Liang BL, Mai WW, Li Y, Guo HC. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis. Abdom Imaging 2007;32:668-674.
34. Francis IR, Cohan RH, Varma DG, Sondak VK. Retroperitoneal sarcomas. Cancer Imaging 2005;5:89-94.
35. Tateishi U, Hasegawa T, Beppu Y, Satake M, Moriyama N. Primary dedifferentiated liposarcoma of the retroperitoneum: prognostic significance of computed tomography and magnetic resonance imaging features. J Comput Assist Tomogr 2003; 27:799-804.
36. Peterson JJ, Kransdorf MJ, Bancroft LW, O'Connor MI. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol 2003;32:493-503.
37. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-365.
38. Potter DA, Glenn J, Kinsella T, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985;3:353-366.
39. Verazin GT, Warneke JA, Driscoll DL, Karakousis C, Petrelli NJ, Takita H. Resection of lung metastases from soft-tissue sarcomas: a multivariate analysis. Arch Surg 1992;127:1407-1411.
40. Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:602-610; discussion 610-612.
41. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-868.
42. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.
43. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235-2241.
44. Bramwell VH. Adjuvant chemotherapy for adult soft tissue sarcoma: is there a standard of care? J Clin Oncol 2001;19:1235-1237.
45. Patel SR, Vadhan-Raj S, Papadopolous N, et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-doseresponse and schedule dependence. J Clin Oncol 1997;15:2378-2384.
46. Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol 2000;18:1637-1643.
47. McCormick D, Mentzel T, Beham A, Fletcher CD. Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 1994;18:1213-1223.
48. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003;238:358-370; discussion 370-371.
49. Huang HY, Brennan MF, Singer S, Antonescu CR. Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol 2005;18:976-984.
50. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001;7:3977-3987.
51. Baird K, Davis S, Antonescu CR, et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 2005;65:9226-9235.
52. O'Sullivan B, Catton C. Soft tissue sarcomas. In: Gospodarowiz M, O'Sullivan B, Sobin L, eds. Prognostic factors in cancer. 3rd ed. New York, NY: Wiley, 2006; 181-186.
53. Alvine G, Rosenthal H, Murphey M, Huntrakoon M. Hibernoma. Skeletal Radiol 1996;25:493-496.
54. Dursun M, Agayev A, Bakir B, et al. CT and MR characteristics of hibernoma: six cases. Clin Imaging 2008;32:42-47.
55. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol 2001;25:809-814.
56. Tomihama RT, Lindskog DM, Ahrens W, Haims AH. Hibernoma: a case report demonstrating usefulness of MR angiography in characterizing the tumor. Skeletal Radiol 2007;36:541-545.
57. Maire G, Forus A, Foa C, et al. 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer 2003;37:389-395.
58. Anderson SE, Schwab C, Stauffer E, Banic A, Steinbach LS. Hibernoma: imaging characteristics of a rare benign soft tissue tumor. Skeletal Radiol 2001;30:590-595.
59. Ritchie DA, Aniq H, Davies AM, Mangham DC, Helliwell TR. Hibernoma: correlation of histopathology and magnetic-resonance-imaging features in 10 cases. Skeletal Radiol 2006;35:579-589.
60. Lee JC, Gupta A, Saifuddin A, et al. Hibernoma: MRI features in eight consecutive cases. Clin Radiol 2006;61:1029-1034.
61. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003;44:1789-1796.
62. Tsuchiya T, Osanai T, Ishikawa A, Kato N, Watanabe Y, Ogino T. Hibernomas show intense accumulation of FDG positron emission tomography. J Comput Assist Tomogr 2006;30:333-336.
63. Smith CS, Teruya-Feldstein J, Caravelli JF, Yeung HW. False-positive findings on 18F-FDG PET/ CT: differentiation of hibernoma and malignant fatty tumor on the basis of fluctuating standardized uptake values. AJR Am J Roentgenol 2008;190: 1091-1096.
64. Cantisani V, Mortele KJ, Glickman JN, et al. Large retroperitoneal hibernoma in an adult male: CT imaging findings with pathologic correlation. Abdom Imaging 2003;28:721-724.
65. Gatcombe HG, Assikis V, Kooby D, Johnstone PA. Primary retroperitoneal teratomas: a review of the literature. J Surg Oncol 2004;86:107-113.
66. Wang RM, Chen CA. Primary retroperitoneal teratoma. Acta Obstet Gynecol Scand 2000;79:707-708.
67. Davidson AJ, Hartman DS, Goldman SM. Mature teratoma of the retroperitoneum: radiologic, pathologic, and clinical correlation. Radiology 1989;172:421-425.
68. Ulbright TM. Gonadal teratomas: a review and speculation. Adv Anat Pathol 2004;11:10-23.
69. Ulbright T. Testicular tumors: general considerations. In: Atlas of tumor pathology: tumors of the testis, adnexa, spermatic cord and scrotum. Washington, DC: Armed Forces Institute of Pathology, 1999; 1-2.
70. Gonzalez-Crussi F. Extragonadal teratomas. Washington, DC: Armed Forces Institute of Pathology, 1982.
71. Azzopardi JG, Mostofi FK, Theiss EA. Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors: the significance and genesis of hematoxylin-staining bodies in the human testis. Am J Pathol 1961;38:207-225.
72. Ueno T, Tanaka YO, Nagata M, et al. Spectrum of germ cell tumors: from head to toe. RadioGraphics 2004;24:387-404.
73. Bellin MF, Duron JJ, Curet P, Dion-Voirin E, Grellet J. Primary retroperitoneal teratoma in the adult: correlation of MRI features with CT and pathology. Magn Reson Imaging 1991;9:263-266.
74. Renato F, Paolo V, Girolamo M, et al. Malignant retroperitoneal teratoma: case report and literature review. Acta Urol Belg 1996;64:49-54.
75. Cadeddu MO, Mamazza J, Schlachta CM, Seshadri PA, Poulin EC. Laparoscopic excision of retroperitoneal tumors: technique and review of the laparoscopic experience. Surg Laparosc Endosc Percutan Tech 2001;11:144-147.
76. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242-253.
77. Lambrianides AL, Walker MM, Rosin RD. Primary retroperitoneal teratoma in adults. Urology 1987;29:310-312.
78. Billmire DF, Grosfeld JL. Teratomas in childhood: analysis of 142 cases. J Pediatr Surg 1986;21: 548-551.
79. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol 2007;189:1119-1123.
80. Kammen BF, Elder DE, Fraker DL, Siegelman ES. Extraadrenal myelolipoma: MR imaging findings. AJR Am J Roentgenol 1998;171:721-723.
81. Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology 1998;208:87-95.
82. Chang KC, Chen PI, Huang ZH, Lin YM, Kuo PL. Adrenal myelolipoma with translocation (3;21) (q25;p11). Cancer Genet Cytogenet 2002;134: 77-80.
83. Bishop E, Eble JN, Cheng L, et al. Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas. Am J Surg Pathol 2006;30:838-843.
84. Rao P, Kenney PJ, Wagner BJ, Davidson AJ. Imaging and pathologic features of myelolipoma. RadioGraphi;cs 1997;17:1373-1385.
85. Nguyen BD. Retroperitoneal extraadrenal myelolipoma: technetium-99m sulfur colloid scintigraphy and CT imaging. Clin Nucl Med 2007;32: 135-138.
86. Han M, Burnett AL, Fishman EK, Marshall FF. The natural history and treatment of adrenal myelolipoma. J Urol 1997;157:1213-1216.
87. Wong KW, Lee IP, Sun WH. Case report: rupture and growth of adrenal myelolipoma in two patients. Br J Radiol 1996;69:873-875.
88. Goldman HB, Howard RC, Patterson AL. Spontaneous retroperitoneal hemorrhage from a giant adrenal myelolipoma. J Urol 1996;155:639.
89. Catalano O. Retroperitoneal hemorrhage due to a ruptured adrenal myelolipoma: a case report. Acta Radiol 1996;37:688-690.
90. Daneshmand S, Quek ML. Adrenal myelolipoma: diagnosis and management. Urol J 2006;3:71-74.
91. Tseng CA, Pan YS, Su YC, Wu DC, Jan CM, Wang WM. Extrarenal retroperitoneal angiomyolipoma: case report and review of the literature. Abdom Imaging 2004;29:721-723.
92. Murphy WM. Tumors of the kidney, bladder and related urinary structures. In: Murphy WM, ed. AFIP atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology, 2004; 101-240.
93. Smirniotopoulos JG. Renal cystic disease associated with tuberous sclerosis. In: Pollack HM, McClennan BL, Dyer RB, Kenney PJ, eds. Clinical urography. 2nd ed. Philadelphia, Pa: Saunders, 2000; 1359-1367.
94. Wagner BJ, Wong-You-Cheong JJ, Davis CJ Jr. Adult renal hamartomas. RadioGraphics 1997;17:155-169.
95. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 1999;12:539-545.
96. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 2003;361: 1348-1349.
97. Dal Cin P, Sciot R, Van Poppel H, Baert L, Van Damme B, Van den Berghe H. Chromosome analysis in angiomyolipoma. Cancer Genet Cytogenet 1997;99:132-134.
98. Israel GM, Bosniak MA, Slywotzky CM, Rosen RJ. CT differentiation of large exophytic renal angiomyolipomas and perirenal liposarcomas. AJR Am J Roentgenol 2002;179:769-773.
99. Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol 1986;135:1121-1124.
100. Yanai H, Sasagawa I, Kubota Y, et al. Spontaneous hemorrhage during pregnancy secondary to renal angiomyolipoma. Urol Int 1996;56: 188-191.
101. Fegan JE, Shah HR, Mukunyadzi P, Schutz MJ. Extrarenal retroperitoneal angiomyolipoma. South Med J 1997;90:59-62.
102. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002;168:1315-1325.
103. Tello R, Blickman JG, Buonomo C, Herrin J. Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 1998;27:131-138.
104. De Luca S, Terrone C, Rossetti SR. Management of renal angiomyolipoma: a report of 53 cases. BJU Int 1999;83:215-218.
105. Steiner MS, Goldman SM, Fishman EK, Marshall FF. The natural history of renal angiomyolipoma. J Urol 1993;150:1782-1786.
106. van Baal JG, Smits NJ, Keeman JN, Lindhout D, Verhoef S. The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 1994;152:35-38.
107. Rimon U, Duvdevani M, Garniek A, et al. Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol 2006;187:762-768.
108. Yip SK, Tan PH, Cheng WS, Li MK, Foo KT. Surgical management of angiomyolipoma: nephron-sparing surgery for symptomatic tumour. Scand J Urol Nephrol 2000;34:32-35.
109. Fazeli-Matin S, Novick AC. Nephron-sparing surgery for renal angiomyolipoma. Urology 1998;52:577-583.